 The ultimate stroke solution
With its proprietary and revolutionary micro-invasive technology, Clearmind Biomedical provides a better and efficient way to treat intracerebral hemorrahge (ICH). The team works with neurosurgeons to formulate ICH solutions and has world-class manufacturing capabilities. Clearmind's device has been proven in clinical studies as the best solution with minimal blood loss, reduced operation time and better neurological recovery. The company was accepted to Y Combinator in 2015. Why We Invested
When compared to traditional open surgery, MIS (minimally invasive surgery) offers a safer and more effective solution for patients. MIS techniques can help patients dramatically reduce post-operative complications, lower readmittance rates and shave hundreds of millions of dollars off a country’s healthcare expenditure. Clearmind Biomedical is a pioneer in developing advanced MIS systems for brain surgeries. Their product, the Axonpen System, is FDA cleared and has demonstrated outstanding performance in patient safety and recovery at a lower overall cost. |
|
© XCEL NEXT VENTURES INC.